Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Salen

Showing results (1-10 of 264) with videos related to

Pageof 27
Sort By:
Digestive Diseases and Sciences|December 1, 1989
Gallstone dissolution therapy with ursodiol. Efficacy and safetyG Salen
Journal of Clinical Gastroenterology|January 1, 1988
Clinical perspective on the treatment of gallstones with ursodeoxycholic acidG Salen
Annals of Internal Medicine|December 1, 1971
Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanismG Salen
Journal of Lipid Research|August 1, 1991
Stereospecific synthesis and two-dimensional 1H-NMR investigation of isoursocholic acidB Dayal, G Salen
The Journal of Clinical Investigation|January 1, 1972
Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosisG Salen, A Polito
Annual Review of Physiology|January 1, 1983
Bile acid synthesisG Salen, S Shefer
The Journal of Laboratory and Clinical Medicine|April 2, 1998
Abnormal cholesterol biosynthesis produced by AY 9944 in the rat leads to skeletal deformities similar to the Smith-Lemli-Opitz syndromeA K Batta, G Salen
Journal of the Neurological Sciences|February 1, 1994
LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosisV M Berginer, G Salen
The Journal of Clinical Investigation|November 1, 1973
The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosisG Salen, S M Grundy
Journal of Lipid Research|May 1, 1974
Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosisG S Tint, G Salen
Pageof 27

Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
Digestive Diseases and Sciences|December 1, 1989
Gallstone dissolution therapy with ursodiol. Efficacy and safetyG Salen
Journal of Clinical Gastroenterology|January 1, 1988
Clinical perspective on the treatment of gallstones with ursodeoxycholic acidG Salen
Annals of Internal Medicine|December 1, 1971
Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanismG Salen
Journal of Lipid Research|August 1, 1991
Stereospecific synthesis and two-dimensional 1H-NMR investigation of isoursocholic acidB Dayal, G Salen
The Journal of Clinical Investigation|January 1, 1972
Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosisG Salen, A Polito
Annual Review of Physiology|January 1, 1983
Bile acid synthesisG Salen, S Shefer
The Journal of Laboratory and Clinical Medicine|April 2, 1998
Abnormal cholesterol biosynthesis produced by AY 9944 in the rat leads to skeletal deformities similar to the Smith-Lemli-Opitz syndromeA K Batta, G Salen
Journal of the Neurological Sciences|February 1, 1994
LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosisV M Berginer, G Salen
The Journal of Clinical Investigation|November 1, 1973
The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosisG Salen, S M Grundy
Journal of Lipid Research|May 1, 1974
Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosisG S Tint, G Salen
Pageof 27